Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Transplant Immunology
|
May 26, 1999
WOFIE augments the immunosuppressive potency of FK-506. Window of opportunity for immunological engagement
B Dresske, N Zavazava, D S Huang, et al.
Transplantation Proceedings
|
August 1, 1990
Expression of soluble class I molecules in healthy persons and renal graft patients
N Zavazava, E Westphal, L Olofsson, et al.
Transplantation Proceedings
|
February 1, 1995
Anti-donor antibodies in allogeneic cornea transplantation
N Zavazava, G Duncker, S Jenisch, et al.
Transplantation Proceedings
|
May 20, 1999
Allopeptide-mediated expression of endothelial Fas-ligand (CD95L) in long-term tolerized heterotopic rat heart grafts
F Fändrich, B Dresske, X Lin, et al.
Journal of Leukocyte Biology
|
June 17, 2000
Oral feeding of an immunodominant MHC donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination
N Zavazava, F Fändrich, X Zhu, et al.
Transplant Immunology
|
June 22, 1999
The role of natural killer cell mediated caspases activation in a graft-versus-host disease model of semiallogeneic small bowel transplantation
F Fändrich, C Zepernick-Kalinski, H Gebhardt, et al.
World Journal of Surgery
|
October 1, 1996
Correlation between graft-versus-host induced immunosuppression and host natural killer cell activity in small bowel transplantation
F Fändrich, J Schröder, B Exner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 1, 1996
In vivo depletion of NKR-P1 positive cells in the recipient prior to small bowel transplantation enhances graft-versus-host disease (GvHD) in the rat
F Fändrich, B Exner, A Papachrysanthou, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
April 1, 1993
[HLA typing in high risk keratoplasty]
N Hirsch, B Nölle, N Zavazava, et al.
Journal of Leukocyte Biology
|
January 14, 1999
Different in vivo tolerogenicity of MHC class I peptides
F Fändrich, X Zhu, J Schröder, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Transplant Immunology
|
May 26, 1999
WOFIE augments the immunosuppressive potency of FK-506. Window of opportunity for immunological engagement
B Dresske, N Zavazava, D S Huang, et al.
Transplantation Proceedings
|
August 1, 1990
Expression of soluble class I molecules in healthy persons and renal graft patients
N Zavazava, E Westphal, L Olofsson, et al.
Transplantation Proceedings
|
February 1, 1995
Anti-donor antibodies in allogeneic cornea transplantation
N Zavazava, G Duncker, S Jenisch, et al.
Transplantation Proceedings
|
May 20, 1999
Allopeptide-mediated expression of endothelial Fas-ligand (CD95L) in long-term tolerized heterotopic rat heart grafts
F Fändrich, B Dresske, X Lin, et al.
Journal of Leukocyte Biology
|
June 17, 2000
Oral feeding of an immunodominant MHC donor-derived synthetic class I peptide prolongs graft survival of heterotopic cardiac allografts in a high-responder rat strain combination
N Zavazava, F Fändrich, X Zhu, et al.
Transplant Immunology
|
June 22, 1999
The role of natural killer cell mediated caspases activation in a graft-versus-host disease model of semiallogeneic small bowel transplantation
F Fändrich, C Zepernick-Kalinski, H Gebhardt, et al.
World Journal of Surgery
|
October 1, 1996
Correlation between graft-versus-host induced immunosuppression and host natural killer cell activity in small bowel transplantation
F Fändrich, J Schröder, B Exner, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
January 1, 1996
In vivo depletion of NKR-P1 positive cells in the recipient prior to small bowel transplantation enhances graft-versus-host disease (GvHD) in the rat
F Fändrich, B Exner, A Papachrysanthou, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|
April 1, 1993
[HLA typing in high risk keratoplasty]
N Hirsch, B Nölle, N Zavazava, et al.
Journal of Leukocyte Biology
|
January 14, 1999
Different in vivo tolerogenicity of MHC class I peptides
F Fändrich, X Zhu, J Schröder, et al.
Page
of 6